Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Chronic Nasal Septum Perforation
Interventions
BIOLOGICAL

Collagen membrane + HUC-MSCs

After separating bilateral nasal septum mucosas via septum reconstruction incision under endoscopy, the clinical grade HUC-MSCs combined with collagen membrane will be transplanted between the bilateral nasal septum mucosas and fixed. The patients will be treated with antibiotics for 1 week, and with naristillae menthae compositae, mucus promoting agent and other drugs for improving microcirculation for 1 month.

Trial Locations (1)

210008

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing

Sponsors
All Listed Sponsors
collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

lead

Chinese Academy of Sciences

OTHER_GOV

NCT02947191 - Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation | Biotech Hunter | Biotech Hunter